Clinical trial
Strategies for Transfusion of Platelets (SToP)
NCT00420914 · Hamilton Health Sciences Corporation, Other · Terminated
Key facts
| NCT number | NCT00420914 |
|---|---|
| Title | Strategies for Transfusion of Platelets (SToP) |
| Official title | Strategies for Transfusion of Platelets (SToP) [Formerly Titled "Evaluation of the Hemostatic Efficacy and Platelet Utilization Rates of Low Versus Standard Dose Platelet Therapy"] |
| Lead sponsor | Hamilton Health Sciences Corporation, Other |
| Collaborators | Dartmouth-Hitchcock Medical Center Haukeland University Hospital Ottawa Hospital Research Institute Cedars-Sinai Medical Center University Health Network, Toronto |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Thrombocytopenia |
| Intervention type | Procedure |
| Interventions | low dose of 2.25 x 10^11 platelets/transfusion (range 1.5 to 2.9) |
| Enrollment | 130 |
| Start date | Oct 1, 2003 |
| First posted | Jan 11, 2007 |
| Last update posted | May 28, 2008 |
| Countries | Canada, Norway, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: